Filing Details
- Accession Number:
- 0001415889-22-012324
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-09 16:33:05
- Reporting Period:
- 2022-12-07
- Accepted Time:
- 2022-12-09 16:33:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1719406 | Nrx Pharmaceuticals Inc. | NRXP | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1303782 | C Jonathan Javitt | C/O Nrx Pharmaceuticals, Inc. 1201 North Market Street, Suite 111 Wilmington DE 19801 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.001 Per Share | Disposition | 2022-12-07 | 400,000 | $1.00 | 12,899,997 | No | 4 | S | Indirect | By Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By Trust |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock, Par Value $0.001 Per Share | 1,422,000 | Indirect | By Trust |
| Common Stock, Par Value $0.001 Per Share | 146,332 | Direct |
Footnotes
- Private sale pursuant to an option granted by the Reporting Person in 2017 in support of a financing for NeuroRx, Inc. Purchaser has agreed to hold the shares for a period of one year.
- Held by the Jonathan Javitt Living Trust. The Reporting Person is a trustee of the Trust.
- Held by the Javitt 2012 Irrevocable Dynasty Trust. The Reporting Person is the grantor of the Trust.
Billionaire Hedge Funds
